ECM
ALPN

Endurant Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Endurant Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21,353
Closed -$694K – 92
2016
Q3 		$694K Buy
21,353
+4,907
+30% +$119K 0.26% 65
2016
Q2 		$303K Buy
16,446
+8,700
+112% +$154K 0.1% 81
2016
Q1 		$129K Hold
7,746
– – 0.04% 85
2015
Q4 		$240K Buy
7,746
+175
+2% +$5.97K 0.08% 76
2015
Q3 		$393K Sell
7,571
-4,054
-35% -$266K 0.13% 69
2015
Q2 		$704K Buy
+11,625
New +$692K 0.21% 76

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Endurant Capital Management's ALPN Position: Q4 2016 in Review

Endurant Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2016, closing a stake of 21,353 shares — an estimated $694K sold.

Endurant Capital Management first reported a position in ALPN in Q2 2015 and held it in 6 quarters. The position peaked at $704K in Q2 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • Endurant Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q4 2016 after selling out during the quarter.
  • Endurant Capital Management sold 21,353 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $694K.
  • Endurant Capital Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 6 quarters.
  • Endurant Capital Management's Alpine Immune Sciences Inc position peaked at $704K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on Endurant Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.